No announcement yet.

HR 810 Updates

  • Filter
  • Time
  • Show
Clear All
new posts

    HR 810 Updates

    I got this from a CRF Newsletter. Will anyone be attending?

    To kick off the Senate stem cell debate, there will be a press conference on July 17th with our Senate champions in support of the Stem Cell Research Enhancement Act, H.R. 810. If you are in the Washington, D.C. area, please join us in room 138 of the Dirksen Senate Office Building on Capitol Hill at 1:30 pm. We will have “Support HR 810” posters and stickers for your use. If you are not able to join us in DC, look for coverage of the event and the Senate stem cell debate on C-SPAN and your local news outlets.

    Keep those calls coming both in Washington, DC and local offices urging Senators to vote yes on H.R. 810. Every call or e-mail makes a difference and is needed to make sure this bill passes, so please enlist your friends and family to do so as well.

    The next four days are our last chance to ensure that each of our Senators is voting YES on HR 810 -- call or e-mail to let them know that it is the will of their constituents and the patient community that they support HR 810. Lets make sure that every Senator understands the groundswell of support for this bill.
    Also, from CAMR, for folks in Idaho:

    CAMR Friends:

    The Senators in Idaho, Senator Larry Craig (R) and Senator Mike Crapo (R),
    need to hear from their constituents who support HR 810. The constituent
    activity in Idaho has been mostly against the bill, and we must turn that
    tide in the next 3 days.

    For those with members and grassroots in Idaho, please get the word out to
    them ASAP to reach out to the 2 offices. Information about how to contact
    the offices is included below. For those CAMR friends who do not have any
    grassroots or membership in Idaho, please make it your goal to find family,
    friends, or acquaintances in that state and ask them to contact the Senators
    in support of HR 810.

    The message can be very simple: Ask the Senators to vote in favor of HR 810
    and let them know you are counting on their support for HR 810 as a vote in
    support of research for therapies and cures. The phone messages should be
    short and to the point; for the email messages, constituents are encouraged
    to relay a personal story about why they want HR 810 passed.

    Thanks and keep up all your great work. With the vote on Tuesday, we have
    just a few days left to press on the Senate!


    Calls can be made to his Washington, DC office at 202.224.2752. Over the
    weekend, you may leave a short voice message - be sure you leave your IDAHO
    phone number or address!

    Emails can be sent by linking to
    <> and clicking on "General Message." Fill
    out the form and again, be sure to leave your IDAHO contact information.


    Calls can be made to his Washington, DC office at 202.224.6142. Over the
    weekend, you may leave a short voice message - be sure you leave your IDAHO
    phone number or address!

    Emails can be sent by linking to
    <> . Fill out the form and again,
    provide your IDAHO contact information.
    Last edited by Steven Edwards; 15 Jul 2006, 11:16 AM.'s worse than we thought. it turns out the people at the white house are not secret muslims, they're nerds.

    ugh... I'd like to get up to the Hill Monday... can't make it work this time though. Thanks for the post Steven.


      I'll try to be there. 'course as a family member/caregiver I won't add as much to the event as others on this board.


        Interesting article on the debate in today's Washington Post, plus an overview of the Senate votes.

        CQ TODAY
        July 14, 2006 – 8:16 p.m.
        High Noon for Debate on Stem Cells
        By Elizabeth B. Crowley, CQ Staff
        The highly anticipated Senate votes on stem cell legislation this week will be the culmination of a lengthy political and moral debate, with implications for lawmakers seeking re-election.

        They also will force President Bush’s hand on his pledge to veto a bill that would expand federally funded embryonic stem cell research.

        Stem Cell Research Divides Lawmakers
        After two days of debate, senators are expected Tuesday to clear a House-passed embryonic stem cell bill (HR 810) and pass two broadly supported Senate-sponsored stem cell measures. The House would then quickly clear the Senate bills, sending all three to Bush.

        Although Senate Majority Leader Bill Frist, R-Tenn., is not up for re-election, he is a potential presidential candidate in 2008, and the issue has political implications for him as well. His surprise break last year with the president and conservatives in his party on embryonic research set up this week’s showdown.

        Many conservatives oppose the research, which opponents equate with abortion, so how GOP senators up for re-election vote on the issue will be a factor in several close races, as they seek to win favor with a public that in polls has shown broad support for such research.

        Election Implications
        The stakes are especially high for freshman Republican Jim Talent of Missouri, who opposes the House bill that would expand the limited supply of embryonic stem cell lines allowed for federal research.

        In addition to Talent’s tight race against Democratic state Auditor Claire McCaskill, Missouri’s November ballot will ask voters to choose whether their constitution should be amended to allow all stem cell research that is authorized under federal law — giving it an even higher profile.

        Talent has said he is against the ballot measure, which has the support of 65 percent of Missourians, according to a recent St. Louis newspaper poll.

        The issue presents an opportunity for Missouri Democrats to attract voters, said Jack Cardetti, a state party spokesman whose caucus has encouraged its candidates to promote the issue.

        “He’s stuck right in the middle between country club Republicans who support stem cell research and the right wing of his party, which adamantly opposes this research,” Cardetti said.

        Meanwhile, McCaskill announced July14 that she planned to discuss stem cell research when she delivered the Democratic response to Bush’s weekly radio address, indicating that Democrats are eager to capitalize on the divisive issue.

        A spokeswoman for Talent could not be reached for comment July 14.

        Some political observers caution that until this election year, a candidate’s position on stem cells has not been a prominent factor for voters. Although there is ample data to support predictions about how voters will react to a vote on taxes or guns, issues such as stem cells are untested, according to Grover Norquist of the conservative Americans for Tax Reform.

        “We won’t know until after the autopsy how it played out,” Norquist said. “The question is, whose autopsy.”

        The embryonic stem cell issue is not as polarizing in another electoral battleground, Pennsylvania. In a June poll, two-term Republican Rick Santorum trailed his Democratic challenger, state Treasurer Bob Casey, 52 percent to 34 percent. Both oppose abortion rights.

        Santorum, however, has spent much more time than Casey in articulating his position. In fact, the structure of the Senate debate is meant to shield Santorum and others who categorically oppose the destruction of embryos. Santorum is the sponsor, with abortion rights supporter and fellow Pennsylvania Republican Arlen Specter, of alternative legislation (S 2754) that would encourage research into ways to obtain stem cells that have the same properties as embryonic lines without destroying embryos.

        The measure is seen as a way to give the most conservative senators a way to vote for stem cell research while opposing the House bill.

        Specter’s name on the bill gives legitimacy to Santorum’s effort and represents political payback for Santorum’s 2004 support in Specter’s primary race against conservative challenger Pat Toomey. Santorum overlooked his ideological similarities with Toomey to help shore up Specter’s political prospects.

        ‘Earthquake’ in Senate
        When Frist announced last year his support of embryonic stem cell research, he said he would ensure an up-or-down vote on all bills relating to stem cells and human cloning research “sometime this Congress.”

        At the time, Specter called the Frist move an “earthquake,” saying the leader “has given cover to the entire Senate” to vote for the House bill in spite of the veto threat.

        Bush had promised a veto of the House bill even before its passage in May 2005, a stance consistent with his Aug. 9, 2001, executive order banning federal funding for research on any embryonic stem cell lines derived after that date.

        In late June, Frist was able to strike a deal to consider the three stem cell bills. Under the agreement, no amendments are allowed and 60 votes are needed for passage.

        The embryonic research vote will not simply be a proxy for the abortion debate — many abortion rights lawmakers make distinctions for moral, scientific and personal reasons.

        Staunch abortion opponents, such as Republicans Orrin G. Hatch of Utah and Gordon H. Smith of Oregon, support the House-passed legislation. They see embryonic stem cells, which can morph into almost any other tissue in the body, as having the potential to help understand and possibly treat a broad range of ailments, such as Alzheimer’s, Parkinson’s and diabetes.

        “This issue is sort of above party. It’s just about human heart, and deeply held personal beliefs,” Smith said last year. He is among those arguing that the House bill is needed to give researchers access to embryonic stem cells that would otherwise be discarded.

        Others, such as Santorum and Tom Coburn, R-Okla, equate the procedure of extracting the stem cells with abortion because the embryos are destroyed in the process.

        Personal stories also play a role in the debate. Specter was diagnosed with Hodgkin’s disease last year, and in the House, some anti-abortion Republicans broke ranks with their leadership by voting for the embryonic research measure. House Energy and Commerce Chairman Joe L. Barton, R-Texas, who voted for passage, spoke about family members who had died of diseases that scientists predict embryonic stem cell research could help.

        The third bill (S 3504) the Senate will consider, by Santorum and Sam Brownback, R-Kan., would make it illegal to perform research on embryos from “fetal farms,” where human embryos could be gestated in a non-human uterus, or from human pregnancies created specifically for the purpose of research. Brownback has been a vocal opponent of embryonic stem cell research.

        Bush is expected to sign both Senate bills if they reach his desk. But the White House has not wavered from its promise to veto the House bill.


          CAMR Press Release

          What: The Coalition for the Advancement of Medical Research (CAMR) is hosting a press conference to discuss the upcoming Senate debate and vote on the Stem Cell Research Enhancement Act, taking place on July 17 and 18.

          When: Monday, July 17, 2006
          1:30 p.m. ET

          Location: Senate Dirksen Office Building, Room 138

          VIPs: Senator Tom Harkin (D-IA)
          Senator Arlen Specter (R-PA)
          Sean Tipton, president, Coalition for the Advancement of Medical Research
          The Honorable Frank Carlucci, on behalf of the Parkinson’s Action Network
          Ms. Cody Unser, on behalf of the Christopher Reeve Foundation
          Miss Toni Bethea, on behalf of the Juvenile Diabetes Research Foundation

          CAMR will also have experts Dr. Robert Goldstein (JDRF) and Dr. Andrew LaBarbera (ASRM) on hand to address any specific questions related to embryonic stem cell research as it pertains to the legislation being debated.

          Background On May 24, 2005, the U.S. House of Representatives passed H.R. 810 -- The Stem Cell Research Enhancement Act -- with strong, bipartisan support. If it passes the Senate, this bill will override President Bush's August 9, 2001 executive order limiting federal funding of embryonic stem cell research. Thousands of scientists, including Nobel laureates, recognize that current federal restrictions on stem cell research seriously hamper research in the United States. Nearly three-quarters of Americans support federal funding for embryonic stem cell research.

          As it does with other kinds of promising technological and medical research, CAMR believes the federal government must fund human embryonic stem cell research. CAMR calls on the Senate to vote for H.R. 810 with no amendments and no alternatives. If this bill does not pass, we not only risk the lives and well-being of millions of Americans and their families, we also risk losing America’s leadership position in the fields of science and medicine.

          # # #

          The Coalition for the Advancement of Medical Research (CAMR) is the nation's leading pro-cures coalition. It is comprised of nationally recognized patient organizations, universities, scientific societies, and foundations advocating for the advancement of breakthrough research and technologies in regenerative medicine - including stem cell research and somatic cell nuclear transfer - in order to cure disease and alleviate suffering for individuals with life-threatening illnesses and disorders.
          Every day I wake up is a good one


            Originally posted by cubsfandc
            I'll try to be there. 'course as a family member/caregiver I won't add as much to the event as others on this board.
            Don't sell yourself short, what you have to say is important. Family members are impacted by SCI too. ALso many out for JD are parents
            Every day I wake up is a good one